Skip to content

Clinical trials

Phase 1/2 Liver Failure trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Failure Phase: Phase 1/2 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20101
20122
20131
20141
20151
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status4
Completed3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Third Affiliated Hospital, Sun Yat-Sen University2
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
ANRS, Emerging Infectious Diseases1
Assistance Publique - Hôpitaux de Paris1
Beijing 302 Hospital1
Beijing Friendship Hospital1
Hexaell Biotech Co., Ltd.1
Quell Therapeutics Limited1
Shahid Beheshti University of Medical Sciences1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Failure13
Liver Diseases3
Fibrosis2
Hepatitis B2
Carcinoma, Hepatocellular1
End Stage Liver Disease1
Fatty Liver1
HIV Infections1
Hepatic Insufficiency1
Hepatitis1

Trials

Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.